SURG · Insider Trading
SurgePays, Inc. Common Stock
Every open-market purchase and sale reported by SURG officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-16 | Laurie Weisberg | Director | A | +315,179 | — |
| 2026-09-14 | David N Keys | Director | A | +315,179 | — |
| 2026-09-08 | David Allen May | Director | A | +315,179 | — |
| 2026-06-05 | David Allen May | Director | Buy | +40,250 | +$21.15K |
| 2026-06-03 | Kevin Brian Cox | CEO & Chairman | A | +500,000 | — |
| 2026-04-07 | Kevin Brian Cox | CEO & Chairman | MIXED | +1,300,000 | +$1.00M |
| 2026-01-05 | Anthony George Evers | Chief Financial Officer | A | +200,000 | — |
| 2025-12-11 | David Allen May | Director | Buy | +38,422 | +$61.65K |
| 2025-06-10 | David Allen May | Director | Sell | −63,000 | −$177.28K |
| 2025-05-27 | Laurie Weisberg | Director | A | +50,000 | — |
| 2025-05-27 | David N Keys | Director | A | +50,000 | — |
| 2025-05-27 | Richard Earl Schurfeld | Director | A | +50,000 | — |
| 2025-05-19 | Kevin Brian Cox | CEO and Chairman of Board | Buy | +15,073 | +$41.45K |
| 2024-12-04 | Kevin Brian Cox | CEO and Chairman of Board | Sell | −35,180 | −$64.08K |
| 2024-12-04 | Anthony George Evers | Chief Financial Officer | Sell | −36,666 | −$68.20K |
| 2024-11-25 | Laurie Weisberg | Director | Buy | +7,808 | +$13.97K |
| 2024-11-20 | Richard Earl Schurfeld | Director | Buy | +3,500 | +$5.59K |
| 2024-11-15 | Anthony George Evers | Chief Financial Officer | Sell | −36,667 | −$58.67K |
| 2024-11-15 | Kevin Brian Cox | CEO and Chairman of Board | Sell | −31,700 | −$50.56K |
| 2015-10-15 | Robert H Blankemeyer | Director | D | −20,000 deriv. | — |
| 2015-10-15 | Jason Stroisch | VP-Marketing & Technology | MIXED | −76,130 | — |
| 2015-10-15 | David Graeme Thomas | Director | U | −3,000 | — |
| 2015-10-15 | Michael Fanning | VP of Domestic Sales | MIXED | −90,943 | — |
| 2015-10-15 | Pamela G Boone | EVP & Chief Financial Officer | MIXED | −242,330 | — |
| 2015-10-15 | David M Hable | President and CEO | MIXED | −185,225 | — |
| 2015-10-15 | Lawrence C Cardinale | Director | U | −44,243 | — |
| 2015-10-15 | Juanita H Hinshaw | Director | U | −336,710 | — |
| 2015-09-21 | Lawrence C Cardinale | Director | M | +10,000 | +$50.00K |
| 2015-09-21 | Juanita H Hinshaw | Director | M | +10,000 | +$50.00K |
| 2015-01-02 | Michael Fanning | VP of Domestic Sales | Sell | −5,000 | −$21.60K |
| 2014-12-29 | Michael Fanning | VP of Domestic Sales | Sell | −13,000 | −$55.23K |
| 2014-12-17 | Pamela G Boone | EVP & Chief Financial Officer | A | +25,000 | — |
| 2014-12-17 | Jason Stroisch | VP-Marketing & Technology | A | +23,000 | — |
| 2014-12-17 | David M Hable | President and CEO | A | +75,000 | — |
| 2014-12-17 | Michael Fanning | VP of Domestic Sales | A | +20,000 | — |
| 2014-12-16 | Robert H Blankemeyer | Director | A | +10,000 deriv. | — |
| 2014-12-16 | David Graeme Thomas | Director | A | +10,000 deriv. | — |
| 2014-12-16 | Lawrence C Cardinale | Director | A | +10,000 deriv. | — |
| 2014-12-16 | Juanita H Hinshaw | Director | A | +10,000 deriv. | — |
| 2014-10-21 | David Graeme Thomas | Director | Buy | +1,000 | +$3.37K |
| 2014-03-27 | David M Hable | President and CEO | Buy | +3,257 | +$9.91K |
| 2014-03-24 | David Graeme Thomas | Director | Buy | +1,000 | +$3.07K |
| 2014-01-14 | Guy R Guarch | Director | M | +10,000 | +$9.00K |
| 2014-01-07 | Michael Fanning | VP of Domestic Sales | Sell | −2,290 | −$7.96K |
| 2014-01-06 | David Graeme Thomas | Director | Buy | +1,000 | +$3.55K |
| 2013-12-23 | Pamela G Boone | EVP & Chief Financial Officer | A | +10,000 deriv. | — |
| 2013-12-23 | Lawrence C Cardinale | Director | M | +10,000 | +$9.00K |
| 2013-12-23 | Jason Stroisch | VP-Marketing & Technology | A | +8,000 deriv. | — |
| 2013-12-23 | Michael Fanning | VP of Domestic Sales | A | +8,000 deriv. | — |
| 2013-12-23 | David M Hable | President and CEO | A | +7,500 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Kevin Brian Cox | CEO & Chairman | 2,070,745 | $325.52K |
| David Allen May | Director | 486,805 | $76.53K |
| Anthony George Evers | Chief Financial Officer | 414,924 | $65.23K |
| David N Keys | Director | 412,059 | $64.78K |
| Laurie Weisberg | Director | 406,868 | $63.96K |
| Richard Earl Schurfeld | Director | 97,501 | $15.33K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SURG quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.